Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02358811 : Evaluation of the Impact of Sleep Apnea on Cerebral Volumetry According to Age
Phase
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria for patients:

- 18-55 or more than 70 years old

- SAOS (AHI>30) never treated before

- consent form signed

Inclusion Criteria for subjects:

- 18-55 or more than 70 years old

- No SAOS (AHI<10)

- consent form signed

Exclusion Criteria (subjects and patients) :

- Contraindication in the practice of MRI: pacemaker, metallic cardiac valve,
intra-ocular metal part

- Contraindication in the injection of Gadolinium (allergy during a previous
radiological examination).

- Type 1 or 2 diabetes

- History of cerebrovascular accident, myocardial infarction, congestive heart failure

- Chronic and/or severe renal insufficiency

- Chronic respiratory failure

- Neurological pathology

- Central origin sleep apnea (AHIcentral > 15)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02358811      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740